Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia.
Allotex has raised $30.0M in total funding. The most recent round was Series B. The last funding was announced in July 2023.
Allotex's investors include Supernova Invest, Panakes Partners, Exor Ventures, KCK Medtech, Junson Capital.
Allotex is headquartered in Boston, United States.
Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia.
Allotex is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Allotex — Funding & Investors." VCBacked, July 9, 2023, https://www.vcbacked.co/company/allotex. Accessed July 31, 2026.
VCBacked. (2023). Allotex — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/allotex
{{cite web |title=Allotex — Funding & Investors |url=https://www.vcbacked.co/company/allotex |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated